◆英語タイトル:NeoDynamics AB - Product Pipeline Analysis, 2017 Update
◆商品コード:DATA8010102
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月27日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
NeoDynamics AB (NeoDynamics) is an independent medical technology company that focuses on the development of medical solutions for the quick detection and treatment of cancer. It is developing the NeoNavia biopsy system that helps collect samples from breast lesions or axillary lymph nodes for diagnostic analysis of breast abnormalities. The NeoNavia biopsy system facilitates the collection of small lesion tissue samples and other difficult to obtain samples such as tumors smaller than 10 mm in diameter, and tumors close to the chest wall and skin. It also helps prevent injury to small or large blood vessels, nerves, thoracic muscles or pneumothorax, during the collection of samples for axillary lymph node biopsies. NeoDynamics is headquartered in Lidingo, Sweden.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company NeoDynamics AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
NeoDynamics AB Company Overview 4
NeoDynamics AB Company Snapshot 4
NeoDynamics AB Pipeline Products and Ongoing Clinical Trials Overview 4
NeoDynamics AB – Pipeline Analysis Overview 7
NeoDynamics AB – Key Facts 7
NeoDynamics AB – Major Products and Services 8
NeoDynamics AB Pipeline Products by Development Stage 9
NeoDynamics AB Pipeline Products Overview 11
Cytotest 11
Cytotest Product Overview 11
Fourier/AS 12
Fourier/AS Product Overview 12
Neonavia Second Generation Biopsy Device 13
Neonavia Second Generation Biopsy Device Product Overview 13
Preferential Radiofrequency Ablation (PRFA) Device 14
Preferential Radiofrequency Ablation (PRFA) Device Product Overview 14
NeoDynamics AB – Key Competitors 15
NeoDynamics AB – Key Employees 16
NeoDynamics AB – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
NeoDynamics AB, Recent Developments 18
Oct 16, 2017: Scientific article on NeoNavia Biopsy System 18
Oct 10, 2017: Research poster presentation on NeoNavia Biopsy System at BSBR 2017 in Dublin 18
Aug 01, 2016: NeoDynamics recruits new CEO Anna Eriksrud 18
Jul 12, 2016: NeoNavia biopsy system receives CE approval 18
Appendix 20
Methodology 20
About GlobalData 22
Contact Us 22
Disclaimer 23
List of Tables
NeoDynamics AB Pipeline Products and Ongoing Clinical Trials Overview 4
NeoDynamics AB Pipeline Products by Equipment Type 5
NeoDynamics AB Pipeline Products by Indication 6
NeoDynamics AB, Key Facts 7
NeoDynamics AB, Major Products and Services 8
NeoDynamics AB Number of Pipeline Products by Development Stage 9
NeoDynamics AB Pipeline Products Summary by Development Stage 10
Cytotest - Product Status 11
Cytotest - Product Description 11
Fourier/AS - Product Status 12
Fourier/AS - Product Description 12
Neonavia Second Generation Biopsy Device - Product Status 13
Neonavia Second Generation Biopsy Device - Product Description 13
Preferential Radiofrequency Ablation (PRFA) Device - Product Status 14
Preferential Radiofrequency Ablation (PRFA) Device - Product Description 14
NeoDynamics AB, Key Employees 16
Glossary 21